How Long Does MDMA (Ecstasy/Molly) Stay in Your System? (2026 Guide)

MDMA (3,4-methylenedioxymethamphetamine) is metabolized primarily by the liver through the CYP2D6 enzyme. The primary metabolic pathway involves demethylation to MDA (3,4-methylenedioxyamphetamine), which is itself a psychoactive substance. MDMA is also metabolized through other pathways to produce HMMA, HMA, and other metabolites.

MDMA has a half-life of approximately 6 to 9 hours, which is moderate compared to other recreational drugs. This means it takes roughly 1.5 to 2.5 days (5-6 half-lives) for MDMA to be substantially cleared from the body after a single dose.

An important pharmacological property: MDMA exhibits autoinhibition — it inhibits the CYP2D6 enzyme that metabolizes it. This means that when you take MDMA, it slows down its own metabolism. If you take a second dose (redosing), blood levels increase disproportionately because CYP2D6 is already inhibited. This is one reason why redosing significantly increases the risk of adverse effects and extends the detection window.

Approximately 65% of an MDMA dose is excreted in urine, with about 10-20% excreted as unchanged MDMA and the rest as metabolites. MDA (the primary metabolite) is what drug tests detect alongside the parent compound MDMA.

MDMA is an amphetamine derivative and is detected under the 'amphetamines' category on standard drug tests. However, the level of specificity depends on the panel:

5-panel test: MDMA can trigger a positive result on the amphetamines screen (500 ng/mL cutoff). However, the standard 5-panel confirmation only requires testing for amphetamine and methamphetamine — it does NOT require specific MDMA confirmation. Whether MDMA is specifically confirmed depends on the laboratory's protocol.

10-panel test: Similar to the 5-panel — MDMA may trigger the amphetamines screen, but specific MDMA confirmation varies.

12-panel test: Most 12-panel tests include specific MDMA testing with its own confirmation cutoff of 250 ng/mL. This means MDMA is both detected and specifically identified.

DOT testing: The DOT amphetamines confirmation now includes MDMA (since 2010). The DOT confirmation test specifically identifies MDMA at 250 ng/mL and MDA at 250 ng/mL.

The bottom line: MDMA will likely produce a positive amphetamines result on any standard drug test panel. Whether it is specifically identified as MDMA (vs. a general 'amphetamines positive') depends on the specific test panel and laboratory.

Note on MDA: MDMA is metabolized to MDA, and MDA is also a controlled substance sold on its own (sometimes called 'sass' or 'Sally'). Drug tests may detect both MDMA and MDA in a user's sample.

Because MDMA is tested under the amphetamines category, the same substances that cause false positive amphetamine results can also cause issues for MDMA testing:

Pseudoephedrine (Sudafed), bupropion (Wellbutrin), phentermine, and other substances that cross-react with amphetamine immunoassays may trigger the initial screen.

Specific to MDMA confirmation testing: GC-MS/LC-MS/MS confirmation is highly specific for MDMA and MDA. Very few substances produce a false positive at the confirmation stage.

Possible cross-reactant: High doses of DXM (dextromethorphan) have been occasionally reported to produce metabolites that interfere with some MDMA assays, though this is uncommon.

Adulterated products: Perhaps the biggest 'false positive' concern is not actually false — many street ecstasy/molly products contain methamphetamine or other amphetamines as adulterants. If your ecstasy pill contained methamphetamine, you will test positive for methamphetamine (not just MDMA). This is a true positive for methamphetamine, not a false positive.

Prescription MDMA: MDMA is being used in FDA-approved clinical trials for PTSD treatment (MDMA-assisted psychotherapy). As of 2026, MDMA is available through specific clinical programs. If you receive MDMA in a clinical setting, document this for the MRO.

MDMA has a moderate half-life (6-9 hours) and is water-soluble, so it clears the body relatively quickly compared to fat-soluble drugs like THC or PCP. Here are evidence-based approaches:

Stop using: A single dose is typically cleared within 2-3 days. If you have redosed or taken multiple doses, allow 3-5 days.

Stay hydrated: MDMA and its metabolites are excreted primarily through urine. Stay normally hydrated. Important safety note: MDMA can cause hyponatremia (dangerously low sodium levels) if you drink excessive water. Do not overhydrate while MDMA is still active.

Allow adequate time: Most users will test negative within 3 days of a single-dose use. For heavy use, 5 days is typically sufficient. These are estimates.

Avoid CYP2D6 inhibitors: Medications that inhibit CYP2D6 (such as fluoxetine/Prozac, paroxetine/Paxil, and some antipsychotics) can slow MDMA metabolism and extend detection windows. These medications also increase MDMA toxicity risk.

Be aware of adulterants: If you took 'ecstasy' or 'molly' that was adulterated with methamphetamine, the meth will take longer to clear (3-7 days) than MDMA itself.

Seek help if needed: If MDMA use has become a pattern, support is available through SAMHSA (1-800-662-4357). MDMA can cause serotonin syndrome, neurotoxicity, and psychological dependence with heavy use.

MDMA will produce a positive result on the amphetamines category of standard employment drug tests. There is no common prescription form of MDMA that would be verified by the MRO (unlike Adderall, which explains an amphetamine positive).

This means: A positive result confirmed as MDMA will be reported as a verified positive. The MRO has no prescription to verify and no legitimate reason to change the result.

Clinical MDMA exception: If you received MDMA as part of an FDA-approved clinical trial or treatment program (MDMA-assisted psychotherapy for PTSD), this would need to be documented and provided to the MRO. This is a relatively new situation and MRO protocols are still evolving.

Adulterated product risk: If you took what you believed to be MDMA but the product actually contained methamphetamine, your test may come back positive for methamphetamine specifically — which may carry additional consequences in some settings.

Timeline for job seekers: A single dose of MDMA is typically cleared within 3 days. If you have an upcoming drug test, allow at least 3-4 days after a single use. For heavy or repeated use, allow 5-7 days. A home drug test kit (testing for amphetamines) can help gauge your status.

For people on probation or parole: MDMA is commonly included in probation drug test panels (especially 10-panel and 12-panel). A positive result will be reported as a violation. MDMA is a Schedule I controlled substance, and possession carries serious criminal penalties.

MDMA is classified as a Schedule I controlled substance under federal law, meaning it has no generally accepted medical use (outside of specific clinical trial/treatment settings) and a high potential for abuse. Possession, manufacturing, and distribution of MDMA are federal and state felonies.

Clinical and therapeutic use: MDMA has shown significant promise in clinical trials for treatment-resistant PTSD. The FDA has granted breakthrough therapy designation for MDMA-assisted psychotherapy. As of 2026, MDMA-assisted therapy is available through specific FDA-approved clinical programs, though it remains a Schedule I substance for all other purposes.

Some states (Oregon, Colorado) have enacted or are considering laws to allow regulated therapeutic use of certain psychedelics, though MDMA legalization remains less advanced than psilocybin at the state level.

Penalties: Federal penalties for MDMA possession can include up to 1 year in prison for a first offense. Manufacturing or distributing MDMA carries much harsher penalties — up to 20 years for a first offense and up to life imprisonment for repeat offenders or cases involving death or serious injury.

For people with prior MDMA convictions: Some states allow expungement of certain drug possession convictions. Check your state's eligibility at secondchanceinfo.com/expungement.

Harm reduction: If you or someone you know uses MDMA, testing kits (such as Marquis reagent test kits) can help identify adulterants in pills or powder. DanceSafe (dancesafe.org) provides drug checking services and harm reduction information.